The latest market report published by Credence Research, Inc. “Bacteriophage Market By Product Type (dsDNA Bacteriophage, ssDNA Bacteriophage, ssRNA Bacteriophage), By Application (Clinical Application, Food & Beverages, Phage Display, Phage Therapy, Environmental Application, Veterinary) – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” The worldwide bacteriophage market was valued at US$ 567.9 million in 2017 and increased to CAGR by 3.9 per cent from 2018 to 2026.
Browse the full report at https://www.acutemarketreports.com/report/bacteriophage-market
Bacteriophages or phages have recently been acknowledged as an effective instrument in contemporary biotechnology through a variety of studies promoting the prospective use of bacteriophages across a number of apps. Researchers have also suggested bacteriophages as a feasible option to antibiotics for a number of antibiotic-resistant bacterial strains. They can also be used as biocontrol agents in the oil and agriculture industries. Bacteriophages have a distinctive application in the petroleum industry, as bacterial fouling often leads to severe harm to gas pipelines, devaluing products and therefore rising capital costs. In addition, bacteriophages may also be used as vaccine cars, for the identification of pathogenic bacterial strain, and as display devices (phage displays) for several antibodies and proteins. Bacteriophages are a varied group of viruses that can be easily manipulated and therefore have a important role to play in studies, therapeutics and biotechnology. Phages not only control the bacterial population, but also help to move genes from one bacterium to another.
The Bacteriophage Particle Study therefore provides insights into genome evolution, bacterial evolution, DNA expression and copying, and thus the growth of new biotechnology. Globally, the incessant increase in bacterial resistance to most antibiotics is becoming a fresh driving factor for phage therapy that utilizes lytic phage particles because these entities are devoid of metabolic functioning and do not have an affinity to eukaryotic cells. In addition, the use of bacteriophage particles in phage vaccination is also emerging as one of the promising preventive methods presently under investigation. Bacteriophageal biosensing equipment, phage-display based choice of biological affinity molecules, food biopreservation, food safety, biocontrol of plant pathogens, corrosion control and biofilm control Considering product kinds, worldwide bacteriophage market classified as ssDNA (single strand DNA) bacteriophage, dsDNA (double strand DNA) bacteriophage In 2017, dsDNA bacteriophage had the largest share of the global market and was expected to continue to lead over the forecast period from 2018 to 2026. DsDNA is the majority of cultivated viruses that have the ability to culminate in the widest spectrum of bacteria and therefore dominates the worldwide market. DsDNA bacteriophage is also widely applicable to phage display systems.
Download Free PDF Sample Request: https://www.acutemarketreports.com/sample-request/59356
In terms of geography, North America held the largest share in the global bacteriophage market due to prominent phage entities in the U.S., faster and first in the world commercialization process in the region, and significantly large patient pool suffering with bacterial infections and growing incidence of anti-biotic resistance. Moreover, established use of bacteriophages in the areas of environment and food and evolved research infrastructure with several initiatives being undertaken introducing breakthrough technologies will further drive the market during the forecast period. Asia Pacific is projected to witness the fastest progress in the global market due to rapidly evolving biotechnology infrastructure, evolving agriculture practices, and equally supportive government initiatives. The key players currently engaged in bacteriophage market include Federal State Scientific Industrial Company MICROGEN, AmpliPhi Biosciences Corporation, EnBiotix, Phage Biotech Ltd., Fixed-Phage Limited, InnoPhage, Pherecydes Pharma, TechnoPhage SA, VersatileBio among others.
Key Market Movements:
- Growing R&D and funding for investigating bacteriophage therapy for clinical application
- Ongoing clinical trials for bacteriophage therapy for multidrug resistant bacterial infections and regulatory approvals for the same
- Increasing applications of bacteriophage in food, environment and veterinary applications
- Ongoing research for establishing bacteriophage as an effective vaccine delivery system
Do Inquiry before buying report at https://www.acutemarketreports.com/inquiry-before-buying/59356
By Product Type (2016–2026; US$ Mn)
- dsDNA Bacteriophage
- ssDNA Bacteriophage
- ssRNA BActeriophage
By Application (2016–2026; US$ Mn)
- Clinical Application
- Food & Beverages
- Phage Display
- Phage Therapy
- Environmental Application
By Geography Segment (2016–2026; US$ Mn)
- North America
- Asia Pacific (APAC)
- Middle East & Africa (MEA)
- Latin America